Cite
Data from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
MLA
John S. Yu, et al. Data from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....efb0503b5fd473508458762bd552d408&authtype=sso&custid=ns315887.
APA
John S. Yu, Radleigh G. Santos, Clemencia Pinilla, Alona Muzikansky, Santosh Kesari, Edward Pan, Glenn J. Lesser, Michael Gruber, Lyndon Kim, Karen Fink, Donald M. O’Rourke, Renato LaRocca, James M. Markert, David M. Peereboom, Michael Glantz, Jay-Jiguang Zhu, William T. Curry, Joseph C. Landolfi, Robert D. Aiken, … Patrick Y. Wen. (2023). Data from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.
Chicago
John S. Yu, Radleigh G. Santos, Clemencia Pinilla, Alona Muzikansky, Santosh Kesari, Edward Pan, Glenn J. Lesser, et al. 2023. “Data from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....efb0503b5fd473508458762bd552d408&authtype=sso&custid=ns315887.